의약품 관련 법령
Normative Instruction 26: Strength Limits for the Registration and Notification of Dynamized Medicinal Products
작성자 | 관리자 | ||
---|---|---|---|
작성일 | 2018-07-25 | 조회수 | 808 |
국가정보 | 남 아메리카>브라질 | ||
출처 | ANVISA | ||
원문 | http://portal.anvisa.gov.br | ||
첨부파일 |
Normative Instruction 26: Strength Limits for the Registration and Notification of Dynamized Medicinal Products
- 이전글 Normative Instruction 25: Therapeutic Indications for the Registration and Notification of Dynamized Medicinal Products
- 다음글 Normative Instruction 27: Reference List for the Safety and Efficacy Evaluation of Dynamized Medicinal Products